Compiled all in one place, read news articles from each of the news categories, about drugs, the pharmaceutical industry, national and international awareness causes, scientific meetings, trending stories and headlines.

Drug News

Added 1 day ago Drug news

Braftovi triplet combination success in BEACON CRC trial in patients with BRAFV600E-mutant metastatic colorectal cancer

Array BioPharma Inc. announced positive results from the interim analysis of the Phase III BEACON CRC trial evaluating the combination...

Added 9 hours ago Drug news

Phase III APeX-2 trial of BCX 7353 reported data for treatment of hereditary angioedema

BioCryst Pharmaceuticals, Inc. announced that the randomized (n=121), double-blind, placebo-controlled, Phase III APeX-2 trial of once-daily, oral BCX 7353 for...

Added 1 day ago Drug news

Phase II data annonuced for once-daily, fixed dose combination asthma treatment

Novartis announced that new phase II data for IND/GLY/MF (QVM 149), an investigational, once-daily, fixed dose combination asthma treatment containing...

Added 9 hours ago Drug news

Stereotaxis launches Stereotaxis Genesis RMN to advance robotic magnetic navigation technology

Stereotaxis the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, introduced Stereotaxis Genesis RMN, the next-generation...

Industry news

Added 1 day ago Industry news

Amryt acquires Aegerion Pharmaceuticals .

Amryt, a biopharmaceutical company focused on rare and orphan diseases, announces that it has reached agreement to acquire Aegerion Pharmaceuticals...

Added 11 days ago Industry news

Servier Pharmaceuticals opens American HQ in Boston.

Servier Pharmaceuticals, a U.S. subsidiary of the global French pharmaceutical company Servier Group, officially opened its American headquarters, expanding its...

Added 12 days ago Industry news

Adynxx Inc. merges with Alliqua Biomedical Inc.

Adynxx, Inc. a clinical-stage biopharmaceutical company leading the development of transcription factor decoy technology and first-in-class therapeutics for the treatment...